▁Introduction 10.375
: 6.51953125
<0x0A> 3.98046875
P 4.65625
rem 4.5546875
ature 3.052734375
▁men 6.78125
op 0.127685546875
ause 0.0088043212890625
▁in 3.55078125
▁middle 4.13671875
- 1.087890625
aged 0.10809326171875
▁women 0.20654296875
▁with 3.55859375
▁ob 6.01171875
es 0.501953125
ity 0.00023829936981201172
▁and 1.9853515625
▁a 3.748046875
▁pre 5.8671875
dis 0.9873046875
position 0.15283203125
▁to 0.29833984375
▁breast 3.69140625
▁cancer 0.04296875
▁is 2.814453125
▁a 1.6962890625
▁complex 4.578125
▁condition 3.74609375
▁that 1.625
▁requires 2.15234375
▁careful 2.82421875
▁consideration 1.9794921875
▁in 3.302734375
▁treatment 4.16796875
▁options 3.23046875
. 0.34228515625
▁This 3.5078125
▁ess 8.4453125
ay 0.002391815185546875
▁a 2.4609375
ims 0.0017118453979492188
▁to 0.034393310546875
▁analyze 5.6953125
▁the 0.464599609375
▁potential 4.1015625
▁ris 3.03515625
ks 0.00047087669372558594
▁and 0.4921875
▁benefits 0.267333984375
▁of 0.236083984375
▁using 4.21484375
▁Met 10.0
op 3.7109375
rol 0.002399444580078125
ol 0.002773284912109375
▁and 3.060546875
▁Nor 7.203125
vas 0.6103515625
c 0.0016021728515625
▁in 1.078125
▁man 6.74609375
aging 0.00521087646484375
▁these 3.677734375
▁sympt 2.814453125
oms 0.012451171875
▁while 5.46484375
▁highlight 5.4609375
ing 0.006023406982421875
▁the 0.455078125
▁cru 6.37109375
cial 0.00714874267578125
▁role 0.978515625
▁of 0.49951171875
▁di 2.951171875
et 0.11968994140625
▁and 0.9775390625
▁sm 8.3046875
oking 0.005641937255859375
▁c 0.400390625
ess 0.0010309219360351562
ation 0.0008625984191894531
▁in 0.685546875
▁optim 5.35546875
izing 0.08746337890625
▁treatment 2.095703125
▁out 1.0380859375
comes 0.0004181861877441406
. 0.171875
<0x0A> 0.49755859375
Body 7.953125
: 4.8046875
<0x0A> 1.6484375
Met 3.119140625
op 0.1304931640625
rol 0.001697540283203125
ol 0.0007529258728027344
▁and 2.138671875
▁Nor 0.22705078125
vas 0.0038471221923828125
c 0.0006723403930664062
▁E 9.328125
ffic 2.62109375
acy 0.0113983154296875
: 1.904296875
<0x0A> 0.0986328125
Met 1.1611328125
op 0.0174407958984375
rol 0.0012750625610351562
ol 0.00026726722717285156
▁and 0.9716796875
▁Nor 0.052734375
vas 0.0006999969482421875
c 0.0006184577941894531
, 5.16796875
▁both 2.005859375
▁commonly 4.28125
▁pres 1.2392578125
cribed 0.0010204315185546875
▁medic 2.486328125
ations 0.15576171875
, 0.69775390625
▁operate 9.2109375
▁through 2.814453125
▁different 1.611328125
▁mechan 0.52099609375
isms 0.000362396240234375
▁to 1.41015625
▁manage 3.626953125
▁men 2.21875
op 0.0458984375
aus 0.298095703125
al 0.0004677772521972656
▁sympt 0.1007080078125
oms 0.0039215087890625
. 0.39453125
▁Met 0.615234375
op 0.00811004638671875
rol 0.0015783309936523438
ol 7.843971252441406e-05
▁belongs 5.00390625
▁to 0.0170440673828125
▁the 0.409423828125
▁beta 1.4306640625
- 0.456787109375
block 0.207275390625
er 0.36669921875
▁class 0.5595703125
▁and 2.052734375
▁primarily 7.73828125
▁controls 5.3984375
▁blood 2.548828125
▁pressure 0.0654296875
▁and 1.5673828125
▁heart 0.30615234375
▁rate 0.1944580078125
, 1.947265625
▁while 0.8408203125
▁Nor 0.206787109375
vas 0.0029468536376953125
c 0.00040435791015625
, 3.15234375
▁a 1.087890625
▁calci 0.427978515625
um 2.110004425048828e-05
▁channel 0.1009521484375
▁block 0.05328369140625
er 0.00496673583984375
, 0.0626220703125
▁rela 4.203125
xes 0.0004527568817138672
▁blood 0.9501953125
▁vessels 0.1671142578125
▁to 1.5234375
▁reduce 1.9326171875
▁hy 4.08984375
pert 0.0018644332885742188
ension 0.005390167236328125
. 0.7373046875
<0x0A> 1.677734375
Met 1.4443359375
op 0.01558685302734375
rol 0.0007605552673339844
ol 0.00014090538024902344
' 3.53515625
s 0.0017175674438476562
▁Pot 7.59375
ential 0.031463623046875
▁Ris 1.876953125
ks 4.76837158203125e-05
▁and 1.287109375
▁Ben 0.1527099609375
ef 4.5418739318847656e-05
its 0.004230499267578125
: 0.2462158203125
<0x0A> 0.01120758056640625
Met 0.8232421875
op 0.00586700439453125
rol 0.0008187294006347656
ol 0.00017976760864257812
' 1.529296875
s 0.0005707740783691406
▁use 4.28125
▁car 4.09765625
ries 0.0006070137023925781
▁potential 2.810546875
▁ris 0.277587890625
ks 2.0742416381835938e-05
▁and 2.337890625
▁benefits 0.1829833984375
▁specific 7.453125
▁to 0.024566650390625
▁middle 3.578125
- 0.04388427734375
aged 0.01123809814453125
▁women 0.29248046875
▁with 0.5458984375
▁ob 0.283203125
es 0.0013408660888671875
ity 4.6253204345703125e-05
▁and 0.31103515625
▁a 0.20556640625
▁pre 0.041717529296875
dis 0.0038604736328125
position 0.0014362335205078125
▁to 0.03228759765625
▁breast 0.04522705078125
▁cancer 0.00589752197265625
. 0.2391357421875
▁A 4.26953125
▁potential 4.12109375
▁benefit 2.33984375
▁of 0.7431640625
▁using 2.576171875
▁Met 0.413330078125
op 0.00812530517578125
rol 0.00048828125
ol 9.465217590332031e-05
▁is 1.416015625
▁its 1.6767578125
▁impact 6.26171875
▁on 0.03399658203125
▁card 3.66796875
i 0.1680908203125
ov 0.007049560546875
asc 0.0002772808074951172
ular 2.3365020751953125e-05
▁health 1.115234375
, 1.0537109375
▁which 1.4736328125
▁may 1.6435546875
▁be 2.4765625
▁especially 3.044921875
▁critical 3.705078125
▁for 0.87255859375
▁ob 3.1796875
ese 0.042327880859375
▁patients 2.59375
▁at 3.80859375
▁a 2.658203125
▁higher 1.2412109375
▁risk 0.03662109375
▁of 0.3740234375
▁heart 1.3984375
▁disease 0.60546875
. 0.333251953125
▁Additionally 3.875
, 0.00241851806640625
▁Met 0.4658203125
op 0.0024089813232421875
rol 0.0006918907165527344
ol 0.0002257823944091797
▁may 1.3603515625
▁help 2.263671875
▁alle 3.115234375
vi 0.00021135807037353516
ate 0.0005202293395996094
▁sympt 2.537109375
oms 0.00417327880859375
▁like 4.33984375
▁hot 0.9111328125
▁flash 0.25390625
es 0.0018768310546875
▁and 0.865234375
▁sleep 3.291015625
▁dist 0.7265625
urban 0.00206756591796875
ces 3.254413604736328e-05
▁associated 2.232421875
▁with 0.00113677978515625
▁men 0.27978515625
op 0.001583099365234375
ause 0.059356689453125
. 0.484130859375
▁However 1.2421875
, 0.0012645721435546875
▁studies 6.41015625
▁suggest 2.806640625
▁that 0.33642578125
▁Met 0.49462890625
op 0.0013971328735351562
rol 0.0007243156433105469
ol 0.00016319751739501953
▁might 4.41796875
▁increase 1.3740234375
▁the 0.291259765625
▁risk 0.101318359375
▁of 0.061981201171875
▁di 4.875
ab 0.03759765625
etes 0.0175933837890625
▁and 0.958984375
▁met 5.4765625
abol 0.002620697021484375
ic 0.0063323974609375
▁synd 0.1739501953125
rome 0.0083160400390625
, 1.31640625
▁which 1.060546875
▁can 1.9306640625
▁comp 3.716796875
ound 2.240234375
▁the 0.861328125
▁challeng 5.52734375
es 0.00820159912109375
▁faced 2.888671875
▁by 0.020477294921875
▁ob 1.49609375
ese 0.0145263671875
▁patients 1.0224609375
. 0.892578125
<0x0A> 0.7314453125
N 0.356201171875
or 0.00151824951171875
vas 0.0028057098388671875
c 0.0003833770751953125
' 0.214111328125
s 0.00142669677734375
▁Pot 0.05712890625
ential 0.00011587142944335938
▁Ris 0.041046142578125
ks 1.9073486328125e-06
▁and 0.0033969879150390625
▁Ben 0.0010576248168945312
ef 1.430511474609375e-06
its 0.0003485679626464844
: 0.0160369873046875
<0x0A> 0.0008549690246582031
On 5.97265625
▁the 0.06231689453125
▁other 0.07757568359375
▁hand 0.0152587890625
, 0.0012006759643554688
▁Nor 0.17236328125
vas 0.0009794235229492188
c 0.0002856254577636719
▁presents 4.546875
▁its 3.982421875
▁own 0.50244140625
▁potential 2.03515625
▁ris 0.270263671875
ks 6.556510925292969e-06
▁and 0.164306640625
▁benefits 0.035400390625
. 1.203125
▁The 2.619140625
▁benefits 5.33984375
▁of 0.406005859375
▁Nor 0.2476806640625
vas 0.00044608116149902344
c 0.0002777576446533203
▁include 0.65087890625
▁its 1.0458984375
▁ability 0.7509765625
▁to 0.001407623291015625
▁reduce 1.7080078125
▁hy 2.63671875
pert 0.00035309791564941406
ension 0.00157928466796875
▁and 0.83544921875
▁improve 1.5966796875
▁blood 0.99755859375
▁flow 0.26220703125
, 1.521484375
▁which 0.57666015625
▁may 1.0634765625
▁help 1.505859375
▁manage 3.39453125
▁men 1.693359375
op 0.01386260986328125
aus 0.13818359375
al 2.3484230041503906e-05
▁sympt 0.03887939453125
oms 0.0005168914794921875
▁such 2.744140625
▁as 0.002506256103515625
▁vas 5.22265625
om 0.086669921875
ot 0.02545166015625
or 0.0011501312255859375
▁sympt 0.342041015625
oms 0.003997802734375
▁and 1.2490234375
▁potentially 8.8671875
▁reduce 2.06640625
▁the 0.385009765625
▁risk 0.2030029296875
▁of 0.04937744140625
▁card 1.1220703125
i 0.01020050048828125
ov 0.0002651214599609375
asc 4.76837158203125e-05
ular 4.649162292480469e-06
▁events 2.310546875
. 0.5927734375
▁However 1.42578125
, 0.0015850067138671875
▁Nor 0.62255859375
vas 0.0002720355987548828
c 0.0003361701965332031
▁has 2.5546875
▁been 0.6962890625
▁linked 0.93701171875
▁to 0.09661865234375
▁peri 5.79296875
pher 0.0220794677734375
al 0.0003082752227783203
▁ed 1.25
ema 0.004497528076171875
, 0.6123046875
▁which 1.30859375
▁could 3.513671875
▁be 1.8349609375
▁problem 2.525390625
atic 0.00048279762268066406
▁for 0.17431640625
▁patients 1.392578125
▁with 0.45068359375
▁ob 1.3564453125
es 0.0196380615234375
ity 5.7578086853027344e-05
. 0.9638671875
▁Furthermore 3.248046875
, 0.000835418701171875
▁its 3.984375
▁potential 1.9921875
▁impact 3.625
▁on 0.0355224609375
▁breast 5.1171875
▁cancer 0.428955078125
▁risk 1.0693359375
▁war 6.65625
r 0.00508880615234375
ants 0.0012216567993164062
▁careful 1.8447265625
▁consideration 0.171630859375
, 2.484375
▁particularly 2.525390625
▁in 1.2412109375
▁women 1.734375
▁already 5.2109375
▁pre 3.703125
dis 0.00923919677734375
posed 0.0012865066528320312
▁to 0.121826171875
▁the 0.7470703125
▁disease 0.1810302734375
. 0.1773681640625
<0x0A> 0.227294921875
D 3.4765625
iet 0.328369140625
▁and 0.41259765625
▁Sm 0.39501953125
oking 0.0012102127075195312
▁Consider 10.734375
ations 0.1087646484375
▁in 3.3203125
▁Tre 1.1474609375
at 0.451904296875
ment 0.01229095458984375
: 0.47412109375
<0x0A> 0.0027065277099609375
Management 7.75
▁of 0.11993408203125
▁prem 7.22265625
ature 0.0019588470458984375
▁men 0.020111083984375
op 0.00025725364685058594
ause 0.01203155517578125
▁in 0.5810546875
▁middle 0.205322265625
- 0.01557159423828125
aged 0.0061798095703125
▁women 0.0625
▁with 0.139892578125
▁ob 0.04638671875
es 0.0007357597351074219
ity 1.1920928955078125e-05
▁and 0.138427734375
▁a 0.0679931640625
▁pre 0.009490966796875
dis 0.00040531158447265625
position 0.0002727508544921875
▁to 0.01284027099609375
▁breast 0.007781982421875
▁cancer 0.0026073455810546875
▁should 3.490234375
▁account 4.77734375
▁for 0.004299163818359375
▁the 0.89501953125
▁significant 5.23046875
▁roles 6.40234375
▁of 1.91796875
▁di 0.260986328125
et 0.00466156005859375
▁and 0.080078125
▁sm 0.03192138671875
oking 8.940696716308594e-05
▁hab 5.34375
its 1.0967254638671875e-05
. 1.0791015625
▁A 2.669921875
▁well 4.6015625
- 0.0200958251953125
des 4.30859375
igned 0.04168701171875
, 3.06640625
▁bal 3.451171875
anced 0.00028824806213378906
▁di 0.16796875
et 0.00018286705017089844
▁that 2.212890625
▁prom 3.759765625
otes 0.0002219676971435547
▁weight 1.32421875
▁loss 0.06817626953125
, 1.7421875
▁such 5.4140625
▁as 0.0021495819091796875
▁the 0.68603515625
▁Mediter 0.57373046875
rane 0.0006346702575683594
an 0.00034499168395996094
▁di 0.6875
et 0.0006475448608398438
, 0.1802978515625
▁can 1.4638671875
▁help 0.826171875
▁address 4.76953125
▁the 1.57421875
▁ob 2.17578125
es 0.006038665771484375
ity 0.0012331008911132812
▁component 3.779296875
▁while 3.5859375
▁impro 3.9140625
ving 0.00013148784637451172
▁overall 2.375
▁health 0.55126953125
▁and 1.08984375
▁reducing 1.32421875
▁the 0.6630859375
▁risk 0.1458740234375
▁of 0.07086181640625
▁card 1.13671875
i 0.005840301513671875
ov 0.01142120361328125
asc 2.6941299438476562e-05
ular 5.602836608886719e-06
▁comp 3.7578125
lications 0.0004978179931640625
. 0.40771484375
▁Sm 1.8369140625
oking 0.0333251953125
▁c 0.45361328125
ess 0.001842498779296875
ation 0.0001995563507080078
▁is 1.1865234375
▁cru 3.255859375
cial 0.0021190643310546875
, 2.833984375
▁as 0.68408203125
▁sm 1.44921875
oking 0.292236328125
▁has 2.251953125
▁been 0.10162353515625
▁consist 4.8203125
ently 0.00012123584747314453
▁associated 1.8359375
▁with 0.0015048980712890625
▁increased 1.9580078125
▁ris 2.96484375
ks 9.059906005859375e-05
▁of 0.24951171875
▁both 4.390625
▁breast 1.3486328125
▁cancer 0.341552734375
▁and 0.033782958984375
▁card 1.3984375
i 0.0038089752197265625
ov 0.0044403076171875
asc 2.002716064453125e-05
ular 2.0623207092285156e-05
▁dise 2.89453125
ases 0.0006241798400878906
. 0.39794921875
▁Im 7.4765625
plement 0.63818359375
ing 0.004207611083984375
▁appropriate 5.83203125
▁di 1.4501953125
et 0.007747650146484375
ary 0.84912109375
▁and 0.583984375
▁sm 0.337158203125
oking 0.00014495849609375
▁c 0.6455078125
ess 7.069110870361328e-05
ation 0.0002961158752441406
▁inter 2.392578125
vent 0.026397705078125
ions 8.416175842285156e-05
▁will 3.6171875
▁maxim 4.5859375
ize 0.00453948974609375
▁treatment 1.7197265625
▁out 0.328369140625
comes 2.765655517578125e-05
. 1.9228515625
<0x0A> 0.09686279296875
Con 2.255859375
clusion 0.2413330078125
: 0.335693359375
<0x0A> 4.7421875
In 2.90234375
▁conclusion 0.47265625
, 0.0027618408203125
▁the 1.72265625
▁potential 2.455078125
▁ris 0.939453125
ks 8.58306884765625e-06
▁and 0.038726806640625
▁benefits 0.01432037353515625
▁of 0.2117919921875
▁using 1.2109375
▁Met 0.048583984375
op 0.004512786865234375
rol 0.00024056434631347656
ol 2.4199485778808594e-05
▁or 3.453125
▁Nor 0.01163482666015625
vas 0.00045609474182128906
c 0.00024199485778808594
▁for 2.32421875
▁tre 1.478515625
ating 9.942054748535156e-05
▁sympt 3.359375
oms 0.0030269622802734375
▁of 0.4267578125
▁prem 0.1546630859375
ature 0.0009350776672363281
▁men 0.00811767578125
op 0.00013899803161621094
ause 0.0019464492797851562
▁in 0.134521484375
▁middle 0.116455078125
- 0.006023406982421875
aged 0.0018062591552734375
▁women 0.07171630859375
▁with 0.031005859375
▁ob 0.038238525390625
es 0.00025153160095214844
ity 6.198883056640625e-06
▁and 0.04608154296875
▁a 0.018524169921875
▁pre 0.003780364990234375
dis 0.00030803680419921875
position 0.0003719329833984375
▁to 0.00574493408203125
▁breast 0.004024505615234375
▁cancer 0.0014085769653320312
▁are 1.779296875
▁complex 1.8759765625
. 1.2294921875
▁A 3.06640625
▁compreh 2.947265625
ensive 0.00148773193359375
▁understanding 2.4140625
▁of 0.0166015625
▁the 0.703125
▁unique 4.43359375
▁characteristics 2.494140625
▁and 2.408203125
▁potential 3.01953125
▁ad 4.1328125
verse 1.6808509826660156e-05
▁effects 0.438232421875
▁of 0.259765625
▁each 0.76171875
▁medic 0.57666015625
ation 0.0005970001220703125
▁is 0.487060546875
▁essential 1.1962890625
. 3.09375
▁Furthermore 3.240234375
, 0.0005197525024414062
▁the 1.8837890625
▁integration 6.0859375
▁of 0.01125335693359375
▁a 1.8203125
▁well 2.248046875
- 0.006122589111328125
bal 0.51220703125
anced 0.0005097389221191406
▁di 0.228271484375
et 0.00014543533325195312
▁and 0.2022705078125
▁sm 0.2425537109375
oking 0.00013267993927001953
▁c 0.00391387939453125
ess 2.753734588623047e-05
ation 9.679794311523438e-05
▁inter 1.6337890625
vent 0.15576171875
ions 3.325939178466797e-05
▁plays 6.10546875
▁a 0.52978515625
▁critical 1.0205078125
▁role 0.005039215087890625
▁in 0.01861572265625
▁optim 1.271484375
izing 0.002197265625
▁the 3.037109375
▁overall 4.01953125
▁treatment 0.85107421875
▁plan 3.9765625
. 0.513671875
▁A 4.0625
▁mult 2.97265625
id 0.131103515625
is 0.00760650634765625
cipl 4.5180320739746094e-05
inary 0.0007081031799316406
▁approach 0.295654296875
▁involving 2.2734375
▁health 3.32421875
care 0.3017578125
▁profession 1.0478515625
als 2.5033950805664062e-06
, 1.8369140625
▁nut 2.5859375
r 0.0004074573516845703
ition 0.0238800048828125
ists 0.107666015625
, 0.015625
▁and 0.2183837890625
▁behavior 2.44921875
al 0.08648681640625
▁ther 1.880859375
ap 0.017913818359375
ists 0.01090240478515625
▁is 0.484619140625
▁necessary 2.654296875
▁to 0.142333984375
▁ensure 1.49609375
▁personal 7.59765625
ized 0.01303863525390625
, 2.228515625
▁hol 2.716796875
istic 0.0007863044738769531
▁care 0.6357421875
▁for 1.517578125
▁these 2.400390625
▁patients 0.30419921875
, 5.21875
▁taking 5.9453125
▁into 0.0576171875
▁account 0.295654296875
▁their 1.0419921875
▁specific 2.16015625
▁medical 2.5859375
▁history 1.5029296875
▁and 0.74609375
▁risk 2.30078125
▁factors 0.0762939453125
. 0.2261962890625
